Health Data Analytics Institute, or HDAI for short, has recently announced a Series C financing round, raising $31 million to expand its predictive risk platform. The Boston-based company leverages artificial intelligence to empower clinicians and improve patient outcomes. Its technology works to transform vast amounts of unstructured health data into actionable insights.
The core technology behind HDAI’s platform is an AI-optimized engine that combines explainable machine learning and generative AI. This product, HealthVision, is already used by health systems such as Houston Methodist, Cleveland Clinic and Dana-Farber Cancer Institute to help them quantify patient and population risks and discern opportunities for clinical performance improvement.
HDAI will put its oversubscribed round toward implementing its HealthVision platform into more health systems across the U.S. Alongside the health systems it serves, HDAI collaborates with more than 40 Medicare accountable care organizations, enabling it to generate 50 million weekly predictions for one million patients.
